Protection against mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 4243-4250

  Velaz Faircloth, Maria ^a,b   Cobb, Alison J ^b   Horstman, Amanda L ^b   Henry, Stanley C ^a   Frothingham, Richard ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MYCOBACTERIUM ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION;

EID: 0032765133     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.4243-4250.1999     Document Type: Article

References (43)

1. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45:115-131.
2. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minóprio. 1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962-3971.
3. Bartlett, R. J., S. L. Secore, J. T. Singer, M. Bodo, K. Sharma, and C. Ricordi. 1996. Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: comparison of human creatine kinase and CMV promoter expression levels in vivo. Cell Transplant. 5:411-419.
4. Bermudez, L. E. 1994. Immunobiology of Mycobacterium avium infection. Eur. J. Clin. Microbiol. Infect. Dis. 13:1000-1006.
5. Centers for Disease Control and Prevention. 1996. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. Morbid. Mortal. Weekly Rep. 45(RR-4):1-18.
6. Chin, D. P., A. L. Reingold, E. N. Stone, E. Vittinghoff, C. R. Horsburgh, Jr., E. M. Simon, D. M. Yajko, W. K. Hadley, S. M. Ostroff, and P. C. Hopewell. 1994. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients - a prospective study. J. Infect. Dis. 170:578-584.
7. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
8. Cormack, B. P., R. H. Valdivia, and S. Falkow. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
9. De Wit, L., A. de la Cuvellerie, J. Ooms, and J. Content. 1990. Nucleotide sequence of the 32 kDa-protein gene (antigen 85A) of Mycobacterium bovis BCG. Nucleic Acids Res. 18:3995.
10. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.
11. El-Zaatari, F. A. K., S. A. Naser, E. Lars, P. E. Burch, C. Y. Hachem, D. L. Whipple, and D. Y. Graham. 1995. Nucleotide sequence analysis and seroreactivities of the 65K heat shock protein from Mycobacterium paratuberculosis. Clin. Diagn. Lab. Immunol. 2:657-664.
12. Erb, K. J., J. Kirman, L. Woodfield, T. Wilson, D. M. Collins, J. D. Watson, and G. LeGros. 1998. Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice. Vaccine 16:692-697.
13. Escuyer, V., N. Haddad, C. Frehel, and P. Berche. 1996. Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium. Microb. Pathog. 20:41-55.
14. Fenton, M. J., and M. W. Vermeulen. 1996. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect. Immun. 64:683-690.
15. Florido, M., R. Appelberg, I. M. Orme, and A. M. Cooper. 1997. Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium. Immunol. 90:600-606.
16. Gangadharam, P. R. J. 1995. Beige mouse model for Mycobacterium avium complex disease. Antimicrob. Agents Chemother. 39:1647-1654.
17. Gruber, R., S. Lederer, U. Bechtel, S. Lob, G. Riethmuller, and H. E. Feucht. 1996. Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis. Int. Arch. Allergy Immunol. 110:95-98.
18. Handley, H. H., J. Yu, D. T. Yu, B. Singh, R. S. Gupta, and J. H. Vaughan. 1996. Autoantibodies to human heat shock protein hsp60 may be induced by Escherichia coli groEL. Clin. Exp. Immunol. 103:429-435.
19. Harshan, K. V., and P. R. J. Gangadharam. 1991. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect. Immun. 59:2818-2821.
20. Holland, S. M., E. M. Eisenstein, D. B. Kuhns, M. L. Turner, T. A. Fleisher, W. Strober, and J. I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. N. Engl. J. Med. 330:1348-1355.
21. Horsburgh, C. R., Jr. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332-1338.
22. Hubbard, R. D., C. M. Flory, and F. M. Collins. 1992. T-cell immune responses in Mycobacterium avium-infected mice. Infect. Immun. 60:150-153.
23. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. Dewitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.-P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
24. Inderlied, C. B., C. A. Kemper, and L. E. M. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.
25. Karopoulos, C., M. J. Rowley, C. J. Handley, and R. A. Strugnell. 1995. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity. J. Autoimmun. 8:235-248.
26. Kobayashi, K., J. Yamazaki, T. Kasama, T. Katsura, K. Kasahara, S. F. Wolf, and T. Shimamura. 1996. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy. J. Infect. Dis. 174:564-573.
27. Kozak, M. 1981. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res. 9:5233-5262.
28. Lozes, E., K. Huygen, J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, P. Vandenbussche, J.-P. Van Vooren, A. Drowart, J. B. Ulmer, and M. A. Liu. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15: 830-833.
29. Migliaccio, G., C. V. Nicchitta, and G. Blobel. 1992. The signal sequence receptor, unlike the signal recognition particle receptor, is not essential for protein translocation. J. Cell Biol. 117:15-25.
30. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941-1949.
31. Ohara, N., K. Matsuo, R. Yamaguchi, A. Yamazaki, H. Tasaka, and T. Yamada. 1993. Cloning and sequencing of the gene for alpha antigen from Mycobacterium avium and mapping of B-cell epitopes. Infect. Immun. 61: 1173-1179.
32. Ohara, N., N. Ohara-Wada, H. Kitaura, T. Nishiyama, S. Matsumoto, and T. Yamada. 1997. Analysis of the genes encoding the antigen 85 complex and MPT51 from Mycobacterium avium. Infect. Immun. 65:3680-3685.
33. Orme, I. M., and F. M. Collins. 1985. Prophylactic effect in mice of BCG vaccination against nontuberculous mycobacterial infections. Tubercle 66: 117-120.
34. Pisetsky, D. S. 1996. Immune activation by bacterial DNA: a new genetic code. Immunity 5:1996.
35. Platzer, C., G. Richter, K. Uberla, W. Muller, H. Blocker, T. Diamantstein, and T. Blankenstein. 1992. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 22:1179-1184.
36. Schell, R. F., W. F. Ealey, G. E. Harding, and D. W. Smith. 1974. The influence of vaccination on the course of experimental airborne tuberculosis in mice. J. Reticuloendothel. Soc. 16:131-138.
37. Sreevatsan, S., X. Pan, K. E. Stockbauer, N. D. Connell, B. N. Kreiswirth, T. S. Whittam, and J. M. Musser. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94:9869-9874.
38. Swanson, D. S., V. Kapur, K. Stockbauer, X. Pan, R. Frothingham, and J. M. Musser. 1997. Subspecific differentiation of Mycobacterium avium complex strains by automated sequencing of a region of the gene (hsp65) encoding a 65-kilodalton heat shock protein. Int. J. Syst. Bacteriol. 47:414-419.
39. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888-892.
40. Weeratna, R., C. L. B. Millan, A. M. Krieg, and H. L. Davis. 1998. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8:351-356.
41. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279.
42. Young, D. B., S. H. Kaufmann, P. W. Hermans, and J. E. Thole. 1992. Mycobacterial protein antigens: a compilation. Mol. Microbiol. 6:133-145.
43. Zhu, X., N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:5921-5926.